Scientists at Israel’s Weizmann Institute have discovered that in addition to cancer-fighting T-cells, the immune system’s B-lymphocytes also produce antibodies that take part in battles against cancer cells. They target the enzyme MMP14, a cause of metastasis and can be used in future therapies.
https://weizmann-usa.org/news-media/news-releases/antibodies-fight-cancer-too/